BioClone Anti-A (Murine Monoclonal Blend) Blood Grouping Reagent
Philippines·Ortho-Clinical Diagnostics Bridgend, United Kingdom Mfd. By: Ortho-Clinical Diagnostics, Inc. - 1001 US Highway 202, Raritan NJ 08869, USA·United Kingdom·Issued September 28, 2022 – October 18, 2027- Product Name
- BioClone Anti-A (Murine Monoclonal Blend) Blood Grouping Reagent
- Registration Number
- RR-1196
- Country of Origin
- United Kingdom
- Importer/Distributor
- Ortho-Clinical Diagnostics Philippines Inc.
- Issuance Date
- September 28, 2022
- Expiry Date
- October 18, 2027
Access comprehensive regulatory information for BioClone Anti-A (Murine Monoclonal Blend) Blood Grouping Reagent in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number RR-1196 and manufactured by Ortho-Clinical Diagnostics Bridgend, United Kingdom Mfd. By: Ortho-Clinical Diagnostics, Inc. - 1001 US Highway 202, Raritan NJ 08869, USA in United Kingdom. The device was registered on September 28, 2022.
This page provides complete registration details including manufacturer information, importer/distributor details (Ortho-Clinical Diagnostics Philippines Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.